EMBASSY OF SWEDEN IN WASHINGTON
The head sponsor for Bridging the Gap 2022 is the Embassy of Sweden in USA which is one of Sweden's largest Embassies and the official link between Sweden and the United States. At the event, the Embassy of Sweden in Washington will be represented by Cecilia Lif, Trade Counselor.
BACK BAY LIFE SCIENCE ADVISORS
Back Bay Life Science Advisors works with international Biopharma, Medtech Guidance and Investment Banking with Emphasis on US-Nordic Growth. The company was founded 12 years ago in Boston's Back Bay neighborhood by a physician with a long academic background and a life science advisor. Since then, Back Bay has become an integral part of the Boston and Nordic life science ecosystem with roots that run around the globe.
With offices in Boston, Frankfurt and Toronto, Back Bay Life Science Advisors is a globally respected boutique consultancy known for pairing expert strategy with investment banking guidance and execution with a special emphasis on US-EU life sciences partnerships, particularly on the Nordic region. Back Bay has completed dozens of strategy and investment banking projects with Swedish, Danish and Norwegian organizations and provides supportive work for Nordic events throughout the year.
Back Bay works to advance biotech, healthtech and medtech development on an international level by partnering with life science innovators that range from global brands to emerging companies, nascent startups, government-backed incubators and academic centers. The Back Bay team, comprised of scientific researchers, biotech executives, physicians, surgeons, bankers and data researchers, excels at partnership and in guiding global life sciences companies and their investors through complex business, scientific, market and transactional challenges.
Back Bay is an industry leader for a reason; they know how to turn data into knowledge. With custom-designed due diligence, primary research, optimal strategy, forecasts and insight, Back Bay offers deeply experienced life science expertise. All of their assignments leverage a comprehensive range of data sources backed by the analytic capabilities of their team, and their integrated strategy and investment teams bring their scientific expertise, clinical knowledge and M&A experience to every project.
They provide solutions that are advantageous and actionable, and Back Bay delivers a keen understanding of the value of new technologies, medicines and scientific approaches. They work with companies across every stage, sector, geography and disease area to position assets for maximum value and impact.
Their strategic analytics have supported work by leading global banks and corporate entities, and Back Bay regularly works with clinicians, opinion leaders, investors, C-suite investors, payors and regulatory experts, across industry and academia.
On Bridging the Gap 2022, Back Bay Life Science Advisors will be presented by Jonathan P. Gertler, MD who will explain the differences among U.S. investor classes and how to prepare your company for on-point discussion.
Read more about Back Bay Life Science Advisors here
Let us introduce one of our amazing sponsors for this year’s Bridging the Gap. Brinter® is a trailblazing Finnish-American 3D bioprinting company. The company makes high-end 3D bioprinting mainstream. Brinter® ONE is an out-of-the-box 3D bioprinting device with several printheads and modules perfected for cancer research, clinical trials, personalized medicine, and stem cell laboratories.
Bioprinting has an important role in the future of life science and Brinter® have a clear vision of what their company’s role is in it.
We would like to share this super interesting article about Brinter®, written by Pharmaceutical-Networking.com. The article is called “The Brinter® vision: accessible bioprinting for life sciences”. It contains information such as an introduction of the Bioprinter platform and how it can be used as a versatile tool for basic research in tissue engineering and regenerative medicine.
Read the full article here.
On Bridging the Gap 2022, Brinter® was presented by Antti Arjonen, Ph.D. Chief Science Officer at Brinter® who discussed the objective view of 3D bioprinting, its current state and its effect on the future of life science.